Cyclodextrins inhibit TRPV1 and TRPA1 activation-induced nociception via cholesterol depletion
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100844 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Andrea Nehr-Majoros und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Pharmacotherapy & Centre for Neuroscience, Faculty of Medicine, University of Pécs, Pécs, Hungary; National Laboratory…. Hauptthemen laut MEDLINE: Cholesterol, TRPA1 Cation Channel, TRPV Cation Channels, Nociception. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pécs Medical School, Hungarian Academy of Sciences, University Of Pécs.
Abstract (Originalsprache)
The nociceptive Transient Receptor Potential Vanilloid 1 (TRPV1) and Ankyrin 1 (TRPA1) channels are predominantly expressed on peptidergic sensory nerves, being involved in pain sensation and neurogenic inflammation induced by local release of pro-inflammatory neuropeptides in the innervation area. Their activation is facilitated by cholesterol-rich lipid microdomains (lipid rafts) in the plasma membrane. Cyclodextrin (CD) derivatives deplete cholesterol from membrane rafts, reducing receptor activation in vitro, anticipating in vivo analgesic effects. We compared three different CD derivatives selected based on our previous results: random methylated β-cyclodextrin, (2-hydroxypropyl)-β-cyclodextrin and sulfobutylether-β-cyclodextrin. The effects of the topical CD pretreatments were evaluated in acute pain and neurogenic vasodilatation models in mice 30 min after TRPV1 (resiniferatoxin) or TRPA1 (formalin or mustard oil) receptor agonist administration. Intraplantar CD pretreatments significantly reduced the duration of nocifensive behaviors during the neurogenic inflammatory phase of the formalin test, as well as mechanical, but not thermal hyperalgesia following resiniferatoxin injection. CD-pretreatment significantly reduced mustard oil-induced acute neurogenic vasodilatation in the mouse ear and decreased the total cholesterol content in the plantar skin and ear tissues. Cholesterol depletion was restored by cholesterol loaded CDs. However, overloading cells with cholesterol did not significantly affect cholesterol depletion. In silico modeling showed that the methylated derivative RAMEB has different cholesterol binding mode compared to HPBCD and SBECD. We present the first in vivo results showing that these CD derivatives are promising agents for exerting peripheral analgesia and anti-inflammation via cholesterol depletion, also supported by our in vitro and in silico findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Pharmacotherapy & Centre for Neuroscience, Faculty of Medicine, University of Pécs, Pécs, Hungary; National Laboratory for Drug Research and Development, Budapest, Hungary.
- Department of Pharmacology and Pharmacotherapy & Centre for Neuroscience, Faculty of Medicine, University of Pécs, Pécs, Hungary.
- Department of Pharmacology and Pharmacotherapy & Centre for Neuroscience, Faculty of Medicine, University of Pécs, Pécs, Hungary; Department of Physiology and Biochemistry, University of Veterinary Medicine, Budapest, H…
- Department of Medical Biology, Faculty of Medicine, University of Pécs, Pécs, Hungary.
- Department of Pharmacology and Pharmacotherapy & Centre for Neuroscience, Faculty of Medicine, University of Pécs, Pécs, Hungary; National Laboratory for Drug Research and Development, Budapest, Hungary; Hungarian Resea…
Förderung
- University of Pécs Medical School
- Hungarian Academy of Sciences
- University Of Pécs
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- Hungarian Research Network
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
Zitieren
APA
Nehr-Majoros, A., Karakai, L., Payrits, M., Bencze, N., Kemény, Á., Sétáló, G., Börzsei, R., Hetényi, C., Helyes, Z., & Szőke, É. (2025). Cyclodextrins inhibit TRPV1 and TRPA1 activation-induced nociception via cholesterol depletion. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100844
Vancouver
Nehr-Majoros A, Karakai L, Payrits M, Bencze N, Kemény Á, Sétáló G, et al. Cyclodextrins inhibit TRPV1 and TRPA1 activation-induced nociception via cholesterol depletion. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100844
BibTeX
@article{NehrMajoros2025,
author = {Nehr-Majoros, Andrea and Karakai, Lajos and Payrits, Maja and Bencze, Noémi and Kemény, Ágnes and Sétáló, György and Börzsei, Rita and Hetényi, Csaba and Helyes, Zsuzsanna and Szőke, Éva},
title = {Cyclodextrins inhibit TRPV1 and TRPA1 activation-induced nociception via cholesterol depletion},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100844}
}
EUVIMED